Guizhi Zhu
Auto-generated profile, based on publicly available information

Guizhi Zhu

Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2017 in Nature Reviews Materials
Verified
Journal Article
Closed access
PDF file
HCHongmin Chen
Hongmin Chen
WZWeizhong Zhang
Weizhong Zhang
GZGuizhi Zhu
Guizhi Zhu
JXJin Xie
Jin Xie
XCXiaoyuan Chen
Xiaoyuan Chen

30 October 2018 in ACS Nano
Verified
Journal Article
Closed access
ZSZheyu Shen
Zheyu Shen
TLTing Liu
Ting Liu
YLYan Li
Yan Li
JLJoseph Lau
Joseph Lau
ZYZhen Yang
Zhen Yang
XCXiaoyuan Chen
Xiaoyuan Chen

29 April 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GZGuizhi Zhu
Guizhi Zhu
JZJing Zheng
Jing Zheng
ESErqun Song
Erqun Song
MDMichael Donovan
Michael Donovan
KZKejing Zhang
Kejing Zhang
WTWeihong Tan
Weihong Tan
Nanotechnology has allowed the construction of various nanostructures for applications, including biomedicine. However, a simple target-specific, economical, and biocompatible drug delivery platform with high maximum tolerated doses is still in demand. Here, we report aptamer-tethered DNA nanotrains (aptNTrs) as carriers for targeted drug transport in cancer therapy. Long aptNTrs were self-assembled from only two short DNA upon initiation by modified aptamers, which worked like locomotives guiding nanotrains toward target cancer cells. Meanwhile, tandem “boxcars” served as carriers with high payload capacity of drugs that were transported to target cells and induced selective cytotoxicity. aptNTrs enhanced maximum tolerated dose in nontarget cells. Potent antitumor efficacy and reduced side effects of drugs delivered by biocompatible aptNTrs were demonstrated in a mouse xenograft tumor model. Moreover, fluorophores on nanotrains and drug fluorescence dequenching upon release allowed intracellular signaling of nanotrains and drugs. These results make aptNTrs a promising targeted drug transport platform for cancer theranostics.

1 September 2018 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
GZGuizhi Zhu
Guizhi Zhu
XCXiaoyuan Chen
Xiaoyuan Chen

8 January 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
YDYunlu Dai
Yunlu Dai
ZYZhen Yang
Zhen Yang
SCSiyuan Cheng
Siyuan Cheng
ZWZhongliang Wang
Zhongliang Wang
RZRuili Zhang
Ruili Zhang
XCXiaoyuan Chen
Xiaoyuan Chen

18 September 2013 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GZGuizhi Zhu
Guizhi Zhu
RHRong Hu
Rong Hu
ZZZilong Zhao
Zilong Zhao
ZCZhuo Chen
Zhuo Chen
XZXiaobing Zhang
Xiaobing Zhang
WTWeihong Tan
Weihong Tan